XML 32 R19.htm IDEA: XBRL DOCUMENT v3.3.1.900
STOCKHOLDERS’ EQUITY AND NONCONTROLLING INTERESTS
 3 Months Ended
Jan. 01, 2016
Equity [Abstract]  
STOCKHOLDERS’ EQUITY AND NONCONTROLLING INTERESTS
STOCKHOLDERS’ EQUITY AND NONCONTROLLING INTERESTS
Share Repurchase Program
In November 2015, the VMS Board of Directors authorized the repurchase of an additional 8,000,000 shares of VMS common stock through December 31, 2016. Share repurchases under the Company's authorizations may be made in open market purchases, in privately negotiated transactions (including accelerated share repurchase programs), or under Rule 10b5-1 share repurchase plans, and may be made from time to time in one or more blocks. All shares that were repurchased under the Company's share repurchase programs have been retired.
The Company repurchased shares of VMS common stock under various authorizations during the periods presented as follows:
 
Three Months Ended
 
January 1,
 
January 2,
(in thousands, except per share amounts)
2016
 
2015
Number of shares
2,425

 
1,500

Average repurchase price per share
$
79.20

 
$
83.69

Total cost
$
192,077

 
$
125,535


As of January 1, 2016, 7,000,000 shares of VMS common stock remained available for repurchase under the November 2015 authorization. Subsequent to January 1, 2016, the Company paid $40.4 million and received 519,186 shares of VMS common stock as part of an accelerated share repurchase.
Other Comprehensive Earnings
The changes in accumulated other comprehensive earnings (loss) by component and related tax effects are summarized as follows:
(in thousands)
Net Unrealized Gains
(Losses) Defined
Benefit Pension and
Post-Retirement
Benefit Plans
 
Net
Unrealized
Gains
(Losses)
Cash Flow
Hedging
Instruments
 
Net
Unrealized
Gains
(Losses)
Available for
Sale
Securities
 
Cumulative
Translation
Adjustment
 
Accumulated
Other
Comprehensive
Earnings
(Loss)
Balance at October 2, 2015
$
(46,070
)
 
$
—

 
$
(112
)
 
$
(40,281
)
 
$
(86,463
)
Other comprehensive earnings before reclassifications
—

 
145

 
(440
)
 
(4,653
)
 
(4,948
)
Amounts reclassified out of other comprehensive earnings
616

 
—

 
604

 
—

 
1,220

Tax expense
(87
)
 
(54
)
 
(52
)
 
—

 
(193
)
Balance at January 1, 2016
$
(45,541
)
 
$
91

 
$
—

 
$
(44,934
)
 
$
(90,384
)

 (in thousands)
Net Unrealized Gain
(Loss) Defined
Benefit Pension and
Post-Retirement
Benefit Plans
 
Net
Unrealized
Gain
(Loss)
Cash Flow
Hedging
Instruments
 
Cumulative
Translation
Adjustment
 
Accumulated
Other
Comprehensive
Earnings
(Loss)
Balance at September 26, 2014
$
(44,060
)
 
$
965

 
$
(15,516
)
 
$
(58,611
)
Other comprehensive earnings before reclassifications
—

 
759

 
(12,290
)
 
(11,531
)
Amounts reclassified out of other comprehensive earnings
541

 
(871
)
 
—

 
(330
)
Tax expense (benefit)
(75
)
 
42

 
—

 
(33
)
Balance at January 2, 2015
$
(43,594
)
 
$
895

 
$
(27,806
)
 
$
(70,505
)

 
The amounts reclassified out of other comprehensive earnings into the Condensed Consolidated Statements of Earnings, with line item location, during each period were as follows: 
 
Three Months Ended
 
 
 
January 1,
 
January 2,
 
 
 (in thousands)
2016
 
2015
 
 
Comprehensive Earnings Components
Income (Loss) Before Taxes
 
Line Item in Statements of Earnings
Unrealized loss on defined benefit pension and post-retirement benefit plans
$
(616
)
 
$
(541
)
 
Cost of revenues & Operating expenses
Unrealized gain on cash flow hedging instruments
—

 
871

 
Revenues
Unrealized loss on available-for-sale-investments
(604
)
 
—

 
Operating expenses
Total amounts reclassified out of other comprehensive earnings
$
(1,220
)
 
$
330

 
 
 
Noncontrolling Interests
In April 2015, the Company completed the acquisition of 73.5% of the then outstanding shares of MeVis Medical Solutions AG ("MeVis"), a public company based in Bremen, Germany that provides image processing software and services for cancer screening.
In August 2015, the Company, through one of its German subsidiaries, entered into a domination and profit and loss transfer agreement (the “DPLTA”) with MeVis. During the three months ended January 1, 2016, the DPLTA became effective upon its registration at the local court of Bremen, Germany. Under the DPLTA, MeVis subordinates its management to the Company and undertakes to transfer all of its annual profits and losses to the Company. In return, the DPLTA grants the noncontrolling shareholders of MeVis: (1) an annual recurring net compensation of €0.95 per MeVis share starting from January 1, 2015 and (2) a put right for their MeVis shares at €19.77 per MeVis share. Upon effectiveness of the DPLTA, the noncontrolling interests in MeVis became redeemable as a result of the put right and were reclassified to temporary equity. As of January 1, 2016, the redemption value of redeemable noncontrolling interests in MeVis was $10.4 million.
During the three months ended January 1, 2016, an immaterial number of MeVis' shares were purchased under the put right. As of January 1, 2016, noncontrolling shareholders together held approximately 482,000 shares of MeVis, representing about 26.5% of the outstanding shares.

Changes in noncontrolling interests and redeemable noncontrolling interests relating to MeVis and other subsidiaries of the Company were as follows:
 (in thousands)
Noncontrolling Interests
 
Redeemable Noncontrolling Interests
Balance at October 2, 2015
$
14,744

 
$
—

Net income attributable to noncontrolling interests
15

 
—

Reclassification of noncontrolling interests in MeVis to redeemable noncontrolling interests
(10,382
)
 
10,382

Other
(499
)
 
—

Balance at January 1, 2016
$
3,878

 
$
10,382